Title: 
Official Title: To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Modern Authentication of Pharmaceuticals Act of 2025.

Section 2:
2.Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain(a)In generalSection 582(a)(9) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee–1(a)(9)) is amended—(1)in subparagraph (A)(ii), by striking and at the end;(2)by redesignating subparagraph (B) as subparagraph (C); and(3)by inserting after subparagraph (A) the following:(B)a physical chemical identifier shall be included in or on each dose of a product that is—(i)a controlled substance (as defined in section 102 of the Controlled Substances Act);(ii)in solid oral dosage form; and(iii)manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025; and.(b)Conforming changes(1)Section 581(14) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(14)) is amended to read as follows:(14)Product identifierThe term product identifier means—(A)a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or(B)a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—(i)is in or on a product;(ii)is machine readable; and(iii)is intended to authenticate the product or a dosage form thereof..(2)Section 581(28) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(28)) is amended to read as follows:(28)Verification or verifyThe term verification or verify means—(A)determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or(B)determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B)..


================================================================================

Raw Text:
119 HR 1060 IH: Modern Authentication of Pharmaceuticals Act of 2025
U.S. House of Representatives
2025-02-06
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 1060IN THE HOUSE OF REPRESENTATIVESFebruary 6, 2025Mr. Davis of North Carolina (for himself, Mr. Rutherford, and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.1.Short titleThis Act may be cited as the Modern Authentication of Pharmaceuticals Act of 2025.2.Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain(a)In generalSection 582(a)(9) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee–1(a)(9)) is amended—(1)in subparagraph (A)(ii), by striking and at the end;(2)by redesignating subparagraph (B) as subparagraph (C); and(3)by inserting after subparagraph (A) the following:(B)a physical chemical identifier shall be included in or on each dose of a product that is—(i)a controlled substance (as defined in section 102 of the Controlled Substances Act);(ii)in solid oral dosage form; and(iii)manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025; and.(b)Conforming changes(1)Section 581(14) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(14)) is amended to read as follows:(14)Product identifierThe term product identifier means—(A)a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or(B)a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—(i)is in or on a product;(ii)is machine readable; and(iii)is intended to authenticate the product or a dosage form thereof..(2)Section 581(28) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(28)) is amended to read as follows:(28)Verification or verifyThe term verification or verify means—(A)determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or(B)determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B)..